BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 17561513)

  • 1. N-terminal truncation of antiapoptotic MCL1, but not G2/M-induced phosphorylation, is associated with stabilization and abundant expression in tumor cells.
    De Biasio A; Vrana JA; Zhou P; Qian L; Bieszczad CK; Braley KE; Domina AM; Weintraub SJ; Neveu JM; Lane WS; Craig RW
    J Biol Chem; 2007 Aug; 282(33):23919-36. PubMed ID: 17561513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia.
    Xiang Z; Luo H; Payton JE; Cain J; Ley TJ; Opferman JT; Tomasson MH
    J Clin Invest; 2010 Jun; 120(6):2109-18. PubMed ID: 20484815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCL1 Is Required for Maintenance of Intestinal Homeostasis and Prevention of Carcinogenesis in Mice.
    Healy ME; Boege Y; Hodder MC; Böhm F; Malehmir M; Scherr AL; Jetzer J; Chan LK; Parrotta R; Jacobs K; Clerbaux LA; Kreutzer S; Campbell A; Gilchrist E; Gilroy K; Rodewald AK; Honcharova-Biletska H; Schimmer R; Vélez K; Büeler S; Cammareri P; Kalna G; Wenning AS; McCoy KD; Gomez de Agüero M; Schulze-Bergkamen H; Klose CSN; Unger K; Macpherson AJ; Moor AE; Köhler B; Sansom OJ; Heikenwälder M; Weber A
    Gastroenterology; 2020 Jul; 159(1):183-199. PubMed ID: 32179094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the translational machinery to overcome apoptosis resistance in pancreatic cancer.
    Wirth M
    Transl Oncol; 2022 Mar; 17():101343. PubMed ID: 35078019
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration.
    Perciavalle RM; Stewart DP; Koss B; Lynch J; Milasta S; Bathina M; Temirov J; Cleland MM; Pelletier S; Schuetz JD; Youle RJ; Green DR; Opferman JT
    Nat Cell Biol; 2012 Apr; 14(6):575-83. PubMed ID: 22544066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule Mcl-1 inhibitors for the treatment of cancer.
    Belmar J; Fesik SW
    Pharmacol Ther; 2015 Jan; 145():76-84. PubMed ID: 25172548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrion-dependent N-terminal processing of outer membrane Mcl-1 protein removes an essential Mule/Lasu1 protein-binding site.
    Warr MR; Mills JR; Nguyen M; Lemaire-Ewing S; Baardsnes J; Sun KL; Malina A; Young JC; Jeyaraju DV; O'Connor-McCourt M; Pellegrini L; Pelletier J; Shore GC
    J Biol Chem; 2011 Jul; 286(28):25098-107. PubMed ID: 21613222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death.
    Domostegui A; Peddigari S; Mercer CA; Iannizzotto F; Rodriguez ML; Garcia-Cajide M; Amador V; Diepstraten ST; Kelly GL; Salazar R; Kozma SC; Kusnadi EP; Kang J; Gentilella A; Pearson RB; Thomas G; Pelletier J
    Blood; 2021 Jun; 137(24):3351-3364. PubMed ID: 33512431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia.
    Rahaman MH; Yu Y; Zhong L; Adams J; Lam F; Li P; Noll B; Milne R; Peng J; Wang S
    Invest New Drugs; 2019 Aug; 37(4):625-635. PubMed ID: 30194564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma.
    Kabashima A; Hirsova P; Bronk SF; Hernandez MC; Truty MJ; Ilyas SI; Kaufmann SH; Gores GJ
    J Hepatol; 2018 Jun; 68(6):1228-1238. PubMed ID: 29408314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined venetoclax and alvocidib in acute myeloid leukemia.
    Bogenberger J; Whatcott C; Hansen N; Delman D; Shi CX; Kim W; Haws H; Soh K; Lee YS; Peterson P; Siddiqui-Jain A; Weitman S; Stewart K; Bearss D; Mesa R; Warner S; Tibes R
    Oncotarget; 2017 Dec; 8(63):107206-107222. PubMed ID: 29291023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion.
    Young AI; Timpson P; Gallego-Ortega D; Ormandy CJ; Oakes SR
    Cell Adh Migr; 2018; 12(6):513-523. PubMed ID: 29166822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cycloheximide Can Induce Bax/Bak Dependent Myeloid Cell Death Independently of Multiple BH3-Only Proteins.
    Goodall KJ; Finch-Edmondson ML; van Vuuren J; Yeoh GC; Gentle IE; Vince JE; Ekert PG; Vaux DL; Callus BA
    PLoS One; 2016; 11(11):e0164003. PubMed ID: 27806040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Function Analysis of the Mcl-1 Protein Identifies a Novel Senescence-regulating Domain.
    Demelash A; Pfannenstiel LW; Tannenbaum CS; Li X; Kalady MF; DeVecchio J; Gastman BR
    J Biol Chem; 2015 Sep; 290(36):21962-75. PubMed ID: 26205817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl2 Family Functions as Signaling Target in Nicotine-/NNK-Induced Survival of Human Lung Cancer Cells.
    Deng X
    Scientifica (Cairo); 2014; 2014():215426. PubMed ID: 24967145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced stability of Mcl1, a prosurvival Bcl2 relative, blunts stress-induced apoptosis, causes male sterility, and promotes tumorigenesis.
    Okamoto T; Coultas L; Metcalf D; van Delft MF; Glaser SP; Takiguchi M; Strasser A; Bouillet P; Adams JM; Huang DC
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):261-6. PubMed ID: 24363325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoding and unlocking the BCL-2 dependency of cancer cells.
    Juin P; Geneste O; Gautier F; Depil S; Campone M
    Nat Rev Cancer; 2013 Jul; 13(7):455-65. PubMed ID: 23783119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programming cancer cells for high expression levels of Mcl1.
    Ertel F; Nguyen M; Roulston A; Shore GC
    EMBO Rep; 2013 Apr; 14(4):328-36. PubMed ID: 23478333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferating cell nuclear antigen (PCNA) interactions in solution studied by NMR.
    De Biasio A; Campos-Olivas R; Sánchez R; López-Alonso JP; Pantoja-Uceda D; Merino N; Villate M; Martin-Garcia JM; Castillo F; Luque I; Blanco FJ
    PLoS One; 2012; 7(11):e48390. PubMed ID: 23139781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancer.
    Nifoussi SK; Vrana JA; Domina AM; De Biasio A; Gui J; Gregory MA; Hann SR; Craig RW
    PLoS One; 2012; 7(10):e47060. PubMed ID: 23056582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.